Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Weigh in: What are the best and worst gifts for people with breast cancer?
Share with us: What are your proudest moments of 2024 and personal goals for 2025?
Take our poll: How are you feeling as we near the New Year?

Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer

moderators
moderators Posts: 8,739
in Targeted Therapy - Before, During, and After

Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer

Dec 17, 2023 

More than eight years of follow-up from the KATHERINE trial showed the continued survival benefits of Kadcyla over Herceptin for HER2-positive breast cancer with a high risk of recurrence. Read more…

Tagged:

Categories

Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.